Gilead’s Captisol-enabled Remdesivir Approved for Use in Renally Impaired Patients
Read full release and find prescribing information
Gilead’s Captisol-enabled Remdesivir Approved for Use in Renally Impaired Patients
Read full release and find prescribing information
Captisol® offers a wide-range of in-depth industry expertise and enables formulation solutions for a variety of products. In addition, Ligand has strong Captisol®-related alliances with partners in various stages including developmental and approved Captisol-enabled® products.
This is a representative listing of Captisol-enabled® partnerships